Canara Bank (CANBK) — Financial Results

Canara Bank reported a 21.69% YoY jump in net profit to ₹4,752 lakh crore for Q1 FY26, driven by 11% revenue growth to ₹8,554 lakh crore, with NIM stabilizing at 2.73% in Q4 FY25 and targeting 2.70%-2.80% for FY26. Gross NPA held at 2.69% and net NPA at 0.63%, while CET1 capital stood at 12.29%. The bank posted a 16.39% YoY rise in fee-based income and maintained priority sector lending at 45.63% of total credit. Operating expenses improved to a 46.77% cost-to-income ratio, and treasury income surged to ₹1,993 crores from ₹995 crores. CEO Satyanarayana Raju highlighted deposit growth of 10% YoY to ₹14.67 lakh crore, with CASA expected to rise to 32% as term deposit rates ease. The bank aims to exceed its 0.6% net NPA target by September, supported by declining slippages and ₹1,200 crores in OTS agreements. With 70-75% of its RAM portfolio targeted for digital conversion by March 2026 and ₹1,000 crore potential PSLC compensation, Canara Bank is positioned for sustained growth amid disciplined capital management and expanding retail and agriculture loan portfolios.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CANBK ✨ Ask AI About This

About Canara Bank (CANBK)

Financial Services · Banks · Listed on NSE

Market Cap: ₹1,16,167.83 Cr P/E: 6.8

View full CANBK stock details →

📡 Get AI alerts when CANBK files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CANBK — Free

💡 Ask AI about this filing

"How does this financial results affect Canara Bank's outlook?" "What did Canara Bank announce on 28 July 2025?" "Is this positive or negative for CANBK?"

Ask AI Free →

📊 More CANBK filings

See all CANBK filings →

🔥 Also filed on 28 July 2025

SHRIRAMFIN Shriram Finance Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Announcement TORNTPHARM Torrent Pharmaceuticals Limited Financial Results RECLTD REC Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CANBK files new disclosures

Track CANBK filings, board meetings, and corporate actions. Free email alerts at 5 PM.